Search Results

Displaying Results 1-3 of 3 "'INZY'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.

Jul 01, 2025, 08:45 ET BioMarin Announces Completion of Acquisition of Inozyme

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) said today that it completed the previously announced agreement to acquire Inozyme Pharma, Inc. (Nasdaq: INZY) for $4.00 per share in an all-cash transaction worth approximately $270 million. The acquisition

More news about: BioMarin Pharmaceutical Inc.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates <em>INZY,</em> SVT, HLGN on Behalf of Shareholders

Jun 12, 2025, 14:30 ET SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INZY, SVT, HLGN on Behalf of Shareholders

multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-inzy-svt-hlgn-on-behalf-of-shareholders-302480471.html

More news about: Halper Sadeh LLP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates <em>INZY,</em> SVT, HLGN on Behalf of Shareholders

Jun 12, 2025, 14:00 ET SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INZY, SVT, HLGN on Behalf of Shareholders

multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-inzy-svt-hlgn-on-behalf-of-shareholders-302480405.html

More news about: Halper Sadeh LLP

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.